These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23073578)

  • 21. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional Epigenetics in Cancer.
    Barrero MJ; Cejas P; Long HW; Ramirez de Molina A
    Adv Nutr; 2022 Oct; 13(5):1748-1761. PubMed ID: 35421212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of epigenetics in aging and age-related diseases.
    Calvanese V; Lara E; Kahn A; Fraga MF
    Ageing Res Rev; 2009 Oct; 8(4):268-76. PubMed ID: 19716530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic information in chromatin and cancer.
    Herceg Z
    Eur J Cancer; 2009 Sep; 45 Suppl 1():442-4. PubMed ID: 19775664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics and pharmacology.
    Stefanska B; MacEwan DJ
    Br J Pharmacol; 2015 Jun; 172(11):2701-4. PubMed ID: 25966315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of epigenetics in cancer initiation and progression.
    Chik F; Szyf M; Rabbani SA
    Adv Exp Med Biol; 2011; 720():91-104. PubMed ID: 21901621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histone modification: a new era of targeting epigenetics].
    Shindo N
    Rinsho Ketsueki; 2009 Apr; 50(4):282-8. PubMed ID: 19404021
    [No Abstract]   [Full Text] [Related]  

  • 28. Histone profiles in cancer.
    Riedel SS; Neff T; Bernt KM
    Pharmacol Ther; 2015 Oct; 154():87-109. PubMed ID: 26210403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics and cancer.
    Kanwal R; Gupta S
    J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer epigenetics: promises and pitfalls for cancer therapy.
    Skourti E; Dhillon P
    FEBS J; 2022 Mar; 289(5):1156-1159. PubMed ID: 35233949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenomics: Roadmap for regulation.
    Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G
    Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562
    [No Abstract]   [Full Text] [Related]  

  • 32. From histones to RNA: role of methylation in cancer.
    Xhemalce B
    Brief Funct Genomics; 2013 May; 12(3):244-53. PubMed ID: 23313959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common features of chromatin in aging and cancer: cause or coincidence?
    Zane L; Sharma V; Misteli T
    Trends Cell Biol; 2014 Nov; 24(11):686-94. PubMed ID: 25103681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the cancer imprintome.
    Monk D
    Brief Funct Genomics; 2010 Jul; 9(4):329-39. PubMed ID: 20551091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetics in Personalized Management of Lung Cancer.
    Ahmad A
    Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation and demethylation of DNA and histones in chromatin: the most complicated epigenetic marker.
    Youn HD
    Exp Mol Med; 2017 Apr; 49(4):e321. PubMed ID: 28450735
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of epigenetic regulation of leukemia onset and progression.
    Ntziachristos P; Mullenders J; Trimarchi T; Aifantis I
    Adv Immunol; 2013; 117():1-38. PubMed ID: 23611284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic control of epigenetics in cancer.
    Kinnaird A; Zhao S; Wellen KE; Michelakis ED
    Nat Rev Cancer; 2016 Nov; 16(11):694-707. PubMed ID: 27634449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication stress, a source of epigenetic aberrations in cancer?
    Jasencakova Z; Groth A
    Bioessays; 2010 Oct; 32(10):847-55. PubMed ID: 20726011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.